Biomerica Profit Margin

Biomerica (BMRA) currently reports a profit margin of -96.49% as of February 2026. That compares with -85.42% in the prior-year period — down 13.0% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Biomerica's profit margin history and peer comparisons.

Biomerica's profit margin decreased from -85.42% to -96.49% — a 13.0% year-over-year decrease (period ending February 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biomerica's profit margin of -96.49% is lower than the Healthcare sector average of 15.29%. That is roughly 730.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biomerica's current -96.49% should be judged against Healthcare norms (sector average: 15.29%) and against BMRA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -96.49%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Biomerica, and consider following BMRA for alerts when major investors trade the stock.